A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 8 March 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in February 2024. To see the la...
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate (Monomil® XL) 60mg modified-release tablets. MSN/2024/034 Tier 2 – medium impact Date of issue: 26th March 2024 Isosorbide mononitrate (Monomil® XL) 60mg modified-release tablets are out of stock until the end of June 2024 Chemydur® 60XL, Isotard® 60XL, Relosorb® [...]
The post Medicine Supply Notification: Isosorbide mononitrate (Monomil® XL) 60mg modified-release tablets appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices. MSN/2024/033 Tier 2 – medium impact Date of issue: 21st March 2024 Levemir® InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices are being discontinued with remaining [...]
The post Medicine Supply Notification: Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices MSN/2024/032 Tier 2 – medium impact Date of issue: 21st March 2024 Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued [...]
The post Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.
Class 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Drug alert number: EL (24)A/10 Date issued: 21 March 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Company name: Fresenius Kabi [...]
The post MHRA Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) appeared first on Community Pharmacy England.
Recent Comments